Applications being accepted for U-M/Israel research partnerships

A program aimed to promote medical research partnerships between University of Michigan scientists and colleagues in Isreal is currently accepting grant applications.  The program's co-director is Dr. David Pinsky, a Taubman Senior Scholar, the division chief of Cardiovascular Medicine at U-M and the scientific director of the U-M Cardiovascular Center.

Awards of $50,000 will support a collaborative research project which requires one principal investigator from U-M and one principal investigator from the Technion Institute of Technology or the Weizman Institute of Science.The purpose of the award is to support meritorious research, to foster innovation and to spur collaboration between two great academic institutions in the areas of medical and life sciences. 

The submission deadline is September 1 and proposals should be emailed to This email address is being protected from spambots. You need JavaScript enabled to view it. . Click here to read the announcement for detailed information.

Save the date for the third annual University of Michigan – Israel Partnership for Research Symposium on Oct. 18 – 21 at the Samuel & Jean Frankel Cardiovascular Center, University of Michigan and the Scientific Symposium on Monday, October 21. More details to follow.

Web Address: http://www.med.umich.edu/CVC-Research/collaboration/index.shtml

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists